Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics

Histopathology

Volumn 58, Issue 2, 2011, Pages 169-179

  Carvalho, Jason C ^a   Wasco, Matthew J ^a   Kunju, Lakshmi P ^a   Thomas, Dafydd G ^a   Shah, Rajal B ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b CARIS LIFE SCIENCES   (United States)

Author keywords

Cluster analysis; Immunohistochemistry; Oncocytoma; Renal cell carcinoma

Indexed keywords

CYTOSKELETON PROTEIN; PROTEIN CK7; PROTEIN S 100; PROTEIN S100A1; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CLUSTER ANALYSIS; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL ONCOCYTOMA; SENSITIVITY AND SPECIFICITY;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KIDNEY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79951637959     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03753.x     Document Type: Article

References (35)

1. Eble J, Sauter G, Epstein JI et al. WHO classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press, 2004.
2. Kunju LP, Wojno K, Wolf JS Jr, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum. Pathol. 2008; 39; 96-101.
3. Shah RB, Bakshi N, Hafez KS, Wood DP Jr, Kunju LP. Image-guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact, and limitations of the pathological diagnosis. Hum. Pathol. 2005; 36; 1309-1315.
4. Cochand-Priollet B, Molinie V, Bougaran J et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch. Pathol. Lab. Med. 1997; 121; 1081-1086.
5. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am. J. Surg. Pathol. 1998; 22; 419-424.
6. Meyer PN, Cao Y, Jacobson K, Krausz T, Flanigan RC, Picken MM. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas. Diagn. Mol. Pathol. 2008; 17; 141-144.
7. Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal. Quant. Cytol. Histol. 2006; 28; 228-236.
8. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24; 203-210.
9. Gupta R, Balzer B, Picken M et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am. J. Surg. Pathol. 2009; 33; 241-247.
10. Huo L, Sugimura J, Tretiakova MS et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum. Pathol. 2005; 36; 262-268.
11. Li G, Barthelemy A, Feng G et al. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2007; 50; 642-647.
12. Martignoni G, Pea M, Chilosi M et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod. Pathol. 2001; 14; 760-767.
13. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod. Pathol. 2005; 18; 535-540.
14. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004; 45; 452-459.
15. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am. J. Surg. Pathol. 2004; 28; 676-678.
16. Rocca PC, Brunelli M, Gobbo S et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod. Pathol. 2007; 20; 722-728.
17. Skinnider BF, Folpe AL, Hennigar RA et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am. J. Surg. Pathol. 2005; 29; 747-754.
18. Wang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2005; 29; 640-646.
19. Molinie V, Balaton A, Rotman S et al. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum. Pathol. 2006; 37; 69-703.
20. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004; 17; 180-188.
21. Allory Y, Bazille C, Vieillefond A et al. Profiling and classification tree applied to renal epithelial tumours. Histopathology 2008; 52; 158-166.
22. Kim SS, Choi YD, Jin XM et al. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2009; 54; 633-635.
23. Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch. Pathol. Lab. Med. 2007; 131; 1290-1297.
24. Li G, Gentil-Perret A, Lambert C, Genin C, Tostain J. S100A1 and KIT gene expressions in common subtypes of renal tumours. Eur. J. Surg. Oncol. 2005; 31; 299-303.
25. Went P, Dirnhofer S, Salvisberg T et al. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am. J. Surg. Pathol. 2005; 29; 83-88.
26. Bakshi N, Kunju LP, Giordano T, Shah RB. Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 310-315.
27. Skapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component. J. Clin. Oncol. 2008; 26; 3809-3811.
28. Memeo L, Jhang J, Assaad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am. J. Clin. Pathol. 2007; 127; 225-229.
29. Ozcan A, Zhai J, Hamilton C et al. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. Am. J. Clin. Pathol. 2009; 131; 393-404.
30. Tretiakova MS, Sahoo S, Takahashi M et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am. J. Surg. Pathol. 2004; 28; 69-76.
31. Szponar A, Beothe T, Kovacs G. How useful is alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in the differential diagnosis of kidney cancers? Histopathology 2010; 56; 263-265.
32. Teratani T, Watanabe T, Kuwahara F et al. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Lett. 2002; 175; 71-77.
33. Mathers ME, Pollock AM, Marsh C, O'Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002; 40; 563-567.
34. Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod. Pathol. 2002; 15; 712-717.
35. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 2004; 121; 878-883.